Kelvin C. Luk

Kelvin C. Luk

Auto-generated profile, based on publicly available information

Kelvin C. Luk

Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2012 in Science
Verified
Journal Article
Closed access
PDF file
KLKelvin C. Luk
Kelvin C. Luk
VKVictoria Kehm
Victoria Kehm
JCJenna Carroll
Jenna Carroll
BZBin Zhang
Bin Zhang
POPatrick O’brien
Patrick O’brien
VLVirginia M.-Y. Lee
Virginia M.-Y. Lee
Synthetic Parkinson's: Parkinson's disease (PD) and related α-synucleinopathies are defined by the accumulation of α-synuclein (α-Syn)–containing intraneuronal inclusions—Lewy bodies (LBs) and Lewy neurites (LNs)—in association with the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and other brain regions. However, a cause-and-effect relationship between LB/LN formation and neurodegeneration remains unclear. Indeed, whether LB/LNs are toxic or represent a neuroprotective response has been contentious. Luk et al. (p. 949 ) injected α-Syn fibrils generated from recombinant mouse α-Syn protein into the dorsal striatum of wild-type mice and found that misfolded α-Syn caused the formation of PD-like LB/LNs and subsequent cell-to-cell transmission of pathologic α-Syn to anatomically interconnected regions, including the SNpc. Furthermore, the formation of LB/LNs and their accumulation in SNpc resulted in the progressive loss of these dopaminergic neurons, reduced dopamine innervations to the dorsal striatum, and culminated in motor deficits similar to PD. Thus, a synthetic misfolded wild-type protein (that is, α-Syn) was able to elicit and transmit disease pathology and neurodegeneration in healthy nontransgenic mice.

1 October 2011 in Neuron
Verified
Journal Article
Closed access
LVLaura A. Volpicelli-Daley
Laura A. Volpicelli-Daley
KLKelvin C. Luk
Kelvin C. Luk
TPTapan P. Patel
Tapan P. Patel
STSelcuk A. Tanik
Selcuk A. Tanik
DRDawn M. Riddle
Dawn M. Riddle
VLVirginia M.-Y. Lee
Virginia M.-Y. Lee

16 April 2012 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
KLKelvin C. Luk
Kelvin C. Luk
VKVictoria M. Kehm
Victoria M. Kehm
BZBin Zhang
Bin Zhang
POPatrick O’brien
Patrick O’brien
JTJohn Q. Trojanowski
John Q. Trojanowski
VLVirginia M.Y. Lee
Virginia M.Y. Lee
The accumulation of misfolded proteins is a fundamental pathogenic process in neurodegenerative diseases. However, the factors that trigger aggregation of α-Synuclein (α-Syn), the principal component of the intraneuronal inclusions known as Lewy bodies (LBs), and Lewy neurites (LNs), which characterize Parkinson’s disease (PD) and dementia with LBs (DLB), are poorly understood. We show here that in young asymptomatic α-Syn transgenic (Tg) mice, intracerebral injections of brain homogenates derived from older Tg mice exhibiting α-Syn pathology accelerate both the formation of intracellular LB/LN-like inclusions and the onset of neurological symptoms in recipient animals. Pathological α-Syn propagated along major central nervous system (CNS) pathways to regions far beyond injection sites and reduced survival with a highly reproducible interval from injection to death in inoculated animals. Importantly, inoculation with α-Syn amyloid fibrils assembled from recombinant human α-Syn induced identical consequences. Furthermore, we show for the first time that synthetic α-Syn fibrils are wholly sufficient to initiate PD-like LBs/LNs and to transmit disease in vivo. Thus, our data point to a prion-like cascade in synucleinopathies whereby cell–cell transmission and propagation of misfolded α-Syn underlie the CNS spread of LBs/LNs. These findings open up new avenues for understanding the progression of PD and for developing novel therapeutics.

24 November 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
KLKelvin C. Luk
Kelvin C. Luk
CSCheng Song
Cheng Song
POPatrick O'Brien
Patrick O'Brien
ASAnna Stieber
Anna Stieber
JBJonathan R. Branch
Jonathan R. Branch
VLVirginia M.-Y. Lee
Virginia M.-Y. Lee
Cytoplasmic inclusions containing α-synuclein (α-Syn) fibrils, referred to as Lewy bodies (LBs), are the signature neuropathological hallmarks of Parkinson's disease (PD). Although α-Syn fibrils can be generated from recombinant α-Syn protein in vitro, the production of fibrillar α-Syn inclusions similar to authentic LBs in cultured cells has not been achieved. We show here that intracellular α-Syn aggregation can be triggered by the introduction of exogenously produced recombinant α-Syn fibrils into cultured cells engineered to overexpress α-Syn. Unlike unassembled α-Syn, these α-Syn fibrils “seeded” recruitment of endogenous soluble α-Syn protein and their conversion into insoluble, hyperphosphorylated, and ubiquitinated pathological species. Thus, this cell model recapitulates key features of LBs in human PD brains. Also, these findings support the concept that intracellular α-Syn aggregation is normally limited by the number of active nucleation sites present in the cytoplasm and that small quantities of α-Syn fibrils can alter this balance by acting as seeds for aggregation.


9 May 2018 in Nature
Verified
Journal Article
Open access
PDF file
CPChao Peng
Chao Peng
RGRonald J. Gathagan
Ronald J. Gathagan
DCDustin J. Covell
Dustin J. Covell
CMCoraima Medellin
Coraima Medellin
ASAnna Stieber
Anna Stieber
VLVirginia M.-Y. Lee
Virginia M.-Y. Lee
In Lewy body diseases—including Parkinson’s disease, without or with dementia, dementia with Lewy bodies, and Alzheimer’s disease with Lewy body co-pathology1—α-synuclein (α-Syn) aggregates in neurons as Lewy bodies and Lewy neurites2. By contrast, in multiple system atrophy α-Syn accumulates mainly in oligodendrocytes as glial cytoplasmic inclusions (GCIs)3. Here we report that pathological α-Syn in GCIs and Lewy bodies (GCI-α-Syn and LB-α-Syn, respectively) is conformationally and biologically distinct. GCI-α-Syn forms structures that are more compact and it is about 1,000-fold more potent than LB-α-Syn in seeding α-Syn aggregation, consistent with the highly aggressive nature of multiple system atrophy. GCI-α-Syn and LB-α-Syn show no cell-type preference in seeding α-Syn pathology, which raises the question of why they demonstrate different cell-type distributions in Lewy body disease versus multiple system atrophy. We found that oligodendrocytes but not neurons transform misfolded α-Syn into a GCI-like strain, highlighting the fact that distinct α-Syn strains are generated by different intracellular milieus. Moreover, GCI-α-Syn maintains its high seeding activity when propagated in neurons. Thus, α-Syn strains are determined by both misfolded seeds and intracellular environments.